Cost Effectiveness of Predicting Severity in Leptospirosis

Galya Ivanova Gancheva

doi:doi:10.11648/j.hep.20160101.14

| Peer-Reviewed

Cost Effectiveness of Predicting Severity in Leptospirosis

Galya Ivanova Gancheva

Published in International Journal of Health Economics and Policy (Volume 1, Issue 1)

Received: 31 October 2016 Accepted: 21 November 2016 Published: 13 January 2017

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The prognosis of leptospirosis depends of severity, early diagnosis and prompt intensive treatment. Only few studies estimate the costs in outbreak of leptospirosis. We aimed to assess the cost effectiveness of predicting severity in leptospirosis by retrospective cohort study of 100 consecutive hospitalized patients with leptospirosis (1976-2015). The prices of service, investigations, drugs and no-medical costs were obtained from valid prices-table of the hospital. Total hospital costs per capita for mild, moderate and severe case were 1184 BGL (Bulgarian Lev=0.5 €), 2111 BGL and 8044 BGL, respectively (ratio 1 to 1.78 to 6.79). The costs for dialysis of severe cases were equal to the costs for drugs and blood products. We concluded that the predicting of severity could be facilitating the decision for prompt treatment including dialysis, decreases the risk for unfavorable outcome and could be decreasing the hospital costs.

Published in	International Journal of Health Economics and Policy (Volume 1, Issue 1)
DOI	10.11648/j.hep.20160101.14
Page(s)	20-25
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2017. Published by Science Publishing Group

Keywords

Leptospirosis, Prognosis, Cost Effectiveness, Global Burden, Dialysis

References

[1]	P. Vijayachari, A. Sugunan, and A. Shiram, “Leptospirosis: an emerging global public health problem,” J Biosci., 2008, vol. 33 (4), pp. 557-569.
[2]	K. Evangelista, and J. Coburn, “Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses,” Future Microbiol., 2010, vol. 5 (9), pp. 1413-1425.
[3]	B. Adler, and A. Moctezuma, “Leptospira and leptospirosis,” Vet. Microbiol., 2010, vol. 140 (3–4), pp. 287-296.
[4]	N. Ahmed, S. Devi, M. Valverde, P. Vijayachari, R. Machang'u, W. Ellis, and R. Hartskeerl, “Multilocus sequence typing method for identification and genotypic classification of pathogenic Leptospira species,” Ann. Clin. Microbiol. Antimicrob., 2006, vol. 5, p. 28.
[5]	WHO. Informal Consultation on Global Burden of Leptospirosis: Methods of Assessment. Geneva, 25-27 October 2006.
[6]	G. Gancheva, “Complex studies upon leptospirosis [dissertation],” Pleven: University of Pleven, 2006, pp. 68-71. (Г. Ганчева. Комплексни проучвания при лептоспироза (дисертация). Медицински университет–Плевен, 2006, c. 68-71.) Bulgarian.
[7]	E. Tasseva, I. Christova, T. Gladnishka, I. Trifonova, and V. Ivanova, “Leptospirosis in humans in Bulgaria–a new challenge for medicine or problem solved. Retrospective analysis of infection for 2010–2011,” Science Infectology/ Parasitology, 2012, vol. 1, pp. 22-29.
[8]	E. Costa, Y. Costa, A. Lopes, E. Sacramento, and J. Bina, “Severe forms of leptospirosis: clinical, demographic and environmental aspects,” Rev. Soc. Bras. Med. Trop., 2001, vol. 34, pp. 261-267.
[9]	E. Daher, R. Lima, G. Silva Jr, E. Silva, N. Karbage, R. Kataoka, P. Carvalho Jr, M. Magalhães, R. Mota, and A. Libório, “Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil,” Braz. J. Infect. Dis., 2010, vol. 14 (1), pp. 3-10.
[10]	E. Daher, D. Soares, A. de Menezes Fernandes, M. Girão, P. Sidrim, E. Pereira, N. Rocha, and G. da Silva Jr, “Risk factors for intensive care unit admission in patients with severe leptospirosis: a comparative study according to patients’ severity,” BMC Infect. Dis., 2016, vol. 16, p. 40.
[11]	A. Spichler, P. Vilaça, D. Athanazio, J. Albuquerque, M. Buzzar, B. Castro, A. Seguro, and J. Vinetz, “Predictors of lethality in severe leptospirosis in urban Brazil,” Am. J. Trop. Med. Hyg., 2008, vol. 79, pp. 911-914.
[12]	G. Gancheva, M. Kostadinova, and H. Ilieva, “Prognostic criteria for severity of leptospirosis,” Meditzinski pregled, 2009, vol. 45, pp. 63-67. (Г. Ганчева, М. Костадинова, Х. Илиева. Прогностични критерии за определяне тежестта на лептоспирозата. Медицински преглед, 2009, бр. 1, c. 63-67.) Bulgarian.
[13]	S. Rajapakse, C. Rodrigo, and R. Haniffa, “Developing a clinically relevant classification to predict mortality in severe leptospirosis,” J. Emerg. Trauma Shock, 2010, vol. 3, pp. 213-219.
[14]	R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans V, et al., “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010,” Lancet, 2012, vol. 380, pp. 2095-128.
[15]	F. Costa, J. Hagan, J. Calcagno, M. Kane, P. Torgerson, M. Martinez-Silveira, C. Stein, B. Abela-Ridder, and A. Ko, “Global morbidity and mortality of leptospirosis: A systematic review,” PloS. Negl. Trop. Dis. 2015, 9: e0003898.
[16]	P. Torgerson, J. Hagan, F. Costa, J. Calcagno, M. Kane, M. Martinez-Silveira, M. Goris, C. Stein, A. Ko, and B. Abela-Ridder, “Global burden of leptospirosis: estimated in terms of disability adjusted life years,” Plos. Negl. Trop. Dis., 2015, 9: e0004122.
[17]	Y. Suputtamongkol, W. Pongtavornpinyo, Y. Lubell, C. Suttinont, S. Hoontrakul, K. Phimda, K. Losuwanaluk, D. Suwancharoen, S. Silpasakorn, W. Chierakul, and N. Day, “Strategies for diagnosis and treatment of suspected leptospirosis: a cost-benefit analysis,” PloS. Negl. Trop. Dis., 2010, 2: e610.
[18]	R. Galloway, P. Levett, J. Tumeh, and C. Flowers, “Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks,” Epidemiol. Infect., 2009, vol. 9, pp. 1323-1332.
[19]	C. Goarant, S. Laumond-Barny, J. Perez, F. Vernel-Pauillac, S. Chanteau, and A. Guigon, “Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease,” Trop. Med. Int. Health, 2009, vol. 8, pp. 926-929.
[20]	C. Pereira, M. Barata, and A. Trigo, “Social cost of leptospirosis cases attributed to the 2011 disaster striking Nova Friburgo, Brazil,” Int. J. Environ. Res. Public Health, 2014, vol. 11 (4), pp. 4140-4157.
[21]	V. Novkirishki, V. Alexandrova, V. Tsankov, B. Bonev, C. Christov, J. Obretenova, P. Tsvetkova, G. Gancheva, H. Boiadjian, E. Kaniovska, L. Naidenova, and P. Christova, “Economical problems of acute viral hepatitis during the epidemic in Pleven Region in 1990-1991,” Proceedings of the 5th Congress of Public Health and Market Economy, Medico-social Risks and Needs–Medical University–Pleven, May 7-9th, 1992. (В. Новкиришки, В. Александрова, В. Цанков, Б. Бонев, Х. Христов, Й. Обретенова, П. Цветкова, Г. Ганчева, Х. Бояджиян, Е. Каньовска, Л. Найденова, П. Христова. Икономически проблеми при вирусния хепатит при епидемичното му разпространение през 1990/91 г. в Плевенски регион. V-ти конгрес по Здравно дело и пазарна икономика; медико-социални рискове и потребности–МУ–Плевен, 7-9 май, 1992 г., Плевен.) Bulgarian.
[22]	S. Gladilov, and E. Delcheva, “Health Economy,” Princeps, Sofia, 2003, p. 401. С. Гладилов, Е. Делчева. Икономика на здравеопазването. Princeps, Cофия, 2003, p. 401. (С. Гладилов, Е. Делчева. Икономика на здравеопазването. Princeps, Cофия, 2003, c. 401.) Bulgarian
[23]	G. Gancheva, P. Ilieva, M. Atanasova, C. Tzvetanova, and I. Simova, “Hemodiaperfusion in Leptospirosis,” Journal of IMAB - Annual Proceeding (Scientific Papers), 2005, vol. 11 (1), pp. 11-12.
[24]	F. Schillinger, N. Babeau, R. Montagnac, T. Milcent, “Severe renal forms of leptospirosis. Apropos 6 cases seen in 15 years at one center,” Nephrologie, 1999, vol. 20 (2), pp. 81-86.
[25]	S. Singh, P. Vijayachari, A. Sinha, A. Sugunan, M. Rasheed, S. Sehgal, “Clinico-epidemiolgical study of hospitalized cases of severe leptospirosis,” Ind. J. of Med. Res., 1999, vol. 109, pp. 94-99.
[26]	V. Souza, M. Arsky, A. Castro, and W. Araujo, “Years of potential life lost and hospitalization costs associated with leptospirosis in Brazil,” Rev. Saude Publica, 2011, vol. 45, pp. 1001-1008.
[27]	R. Reis, G. Ribeiro, R. Felzemburgh, F. Santana, S. Mohr, A. Melendez, A. Queiroz, A. Santos, R. Ravines, W. Tassinari, M. Carvalho, M. Reis, and A. Ko. “Impact of environment and social gradient on Leptospira infection in urban slums,” PLoS Negl. Trop. Dis., 2008, 2: e228.
[28]	R. Felzemburgh, G. Ribeiro, F. Costa, R. Reis, J. Hagan, A. Melendez, D. Fraga, F. Santana, S. Mohr, B. dos Santos, A. Silva, A. Santos, R. Ravines, W. Tassinari, M. Carvalho, M. Reis, and A. Ko, “Prospective study of leptospirosis transmission in an urban slum community: role of poor environment in repeated exposures to the Leptospira agent,” PLoS Negl. Trop. Dis., 2014, 8: e2927.
[29]	K. Durski, M. Jancloes, T. Chowdhary, E. Bertherat, “A global, multi-disciplinary, multi-sectorial initiative to combat leptospirosis: Global Leptospirosis Environmental Action Network (GLEAN),” Int. J. Environ. Res. Public Health, 2014, vol. 11 (6), 6000-6008.
[30]	J. Arbiol, M. Borja, M. Yabe, H. Nomura, N. Gloriani, and S. Yoshida, “Valuing human leptospirosis prevention using the opportunity cost of labor,” Int. J. Environ. Res. Public Health, 2013, vol. 10 (5), 1845-1860.

Cite This Article

Plain Text BibTeX RIS

APA Style

Galya Ivanova Gancheva. (2017). Cost Effectiveness of Predicting Severity in Leptospirosis. International Journal of Health Economics and Policy, 1(1), 20-25. https://doi.org/10.11648/j.hep.20160101.14

Copy | Download

ACS Style

Galya Ivanova Gancheva. Cost Effectiveness of Predicting Severity in Leptospirosis. Int. J. Health Econ. Policy 2017, 1(1), 20-25. doi: 10.11648/j.hep.20160101.14

Copy | Download

AMA Style

Galya Ivanova Gancheva. Cost Effectiveness of Predicting Severity in Leptospirosis. Int J Health Econ Policy. 2017;1(1):20-25. doi: 10.11648/j.hep.20160101.14

Copy | Download

@article{10.11648/j.hep.20160101.14,
  author = {Galya Ivanova Gancheva},
  title = {Cost Effectiveness of Predicting Severity in Leptospirosis},
  journal = {International Journal of Health Economics and Policy},
  volume = {1},
  number = {1},
  pages = {20-25},
  doi = {10.11648/j.hep.20160101.14},
  url = {https://doi.org/10.11648/j.hep.20160101.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hep.20160101.14},
  abstract = {The prognosis of leptospirosis depends of severity, early diagnosis and prompt intensive treatment. Only few studies estimate the costs in outbreak of leptospirosis. We aimed to assess the cost effectiveness of predicting severity in leptospirosis by retrospective cohort study of 100 consecutive hospitalized patients with leptospirosis (1976-2015). The prices of service, investigations, drugs and no-medical costs were obtained from valid prices-table of the hospital. Total hospital costs per capita for mild, moderate and severe case were 1184 BGL (Bulgarian Lev=0.5 €), 2111 BGL and 8044 BGL, respectively (ratio 1 to 1.78 to 6.79). The costs for dialysis of severe cases were equal to the costs for drugs and blood products. We concluded that the predicting of severity could be facilitating the decision for prompt treatment including dialysis, decreases the risk for unfavorable outcome and could be decreasing the hospital costs.},
 year = {2017}
}

Copy | Download

TY  - JOUR
T1  - Cost Effectiveness of Predicting Severity in Leptospirosis
AU  - Galya Ivanova Gancheva
Y1  - 2017/01/13
PY  - 2017
N1  - https://doi.org/10.11648/j.hep.20160101.14
DO  - 10.11648/j.hep.20160101.14
T2  - International Journal of Health Economics and Policy
JF  - International Journal of Health Economics and Policy
JO  - International Journal of Health Economics and Policy
SP  - 20
EP  - 25
PB  - Science Publishing Group
SN  - 2578-9309
UR  - https://doi.org/10.11648/j.hep.20160101.14
AB  - The prognosis of leptospirosis depends of severity, early diagnosis and prompt intensive treatment. Only few studies estimate the costs in outbreak of leptospirosis. We aimed to assess the cost effectiveness of predicting severity in leptospirosis by retrospective cohort study of 100 consecutive hospitalized patients with leptospirosis (1976-2015). The prices of service, investigations, drugs and no-medical costs were obtained from valid prices-table of the hospital. Total hospital costs per capita for mild, moderate and severe case were 1184 BGL (Bulgarian Lev=0.5 €), 2111 BGL and 8044 BGL, respectively (ratio 1 to 1.78 to 6.79). The costs for dialysis of severe cases were equal to the costs for drugs and blood products. We concluded that the predicting of severity could be facilitating the decision for prompt treatment including dialysis, decreases the risk for unfavorable outcome and could be decreasing the hospital costs.
VL  - 1
IS  - 1
ER  -

Copy | Download

Author Information

Galya Ivanova Gancheva

Department of Infectious Diseases, Epidemiology, Parasitology and Tropical Medicine, Faculty of Public Health, Medical University-Pleven, Pleven, Bulgaria

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Galya Ivanova Gancheva. (2017). Cost Effectiveness of Predicting Severity in Leptospirosis. International Journal of Health Economics and Policy, 1(1), 20-25. https://doi.org/10.11648/j.hep.20160101.14

Copy | Download

ACS Style

Galya Ivanova Gancheva. Cost Effectiveness of Predicting Severity in Leptospirosis. Int. J. Health Econ. Policy 2017, 1(1), 20-25. doi: 10.11648/j.hep.20160101.14

Copy | Download

AMA Style

Galya Ivanova Gancheva. Cost Effectiveness of Predicting Severity in Leptospirosis. Int J Health Econ Policy. 2017;1(1):20-25. doi: 10.11648/j.hep.20160101.14

Copy | Download

@article{10.11648/j.hep.20160101.14,
  author = {Galya Ivanova Gancheva},
  title = {Cost Effectiveness of Predicting Severity in Leptospirosis},
  journal = {International Journal of Health Economics and Policy},
  volume = {1},
  number = {1},
  pages = {20-25},
  doi = {10.11648/j.hep.20160101.14},
  url = {https://doi.org/10.11648/j.hep.20160101.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hep.20160101.14},
  abstract = {The prognosis of leptospirosis depends of severity, early diagnosis and prompt intensive treatment. Only few studies estimate the costs in outbreak of leptospirosis. We aimed to assess the cost effectiveness of predicting severity in leptospirosis by retrospective cohort study of 100 consecutive hospitalized patients with leptospirosis (1976-2015). The prices of service, investigations, drugs and no-medical costs were obtained from valid prices-table of the hospital. Total hospital costs per capita for mild, moderate and severe case were 1184 BGL (Bulgarian Lev=0.5 €), 2111 BGL and 8044 BGL, respectively (ratio 1 to 1.78 to 6.79). The costs for dialysis of severe cases were equal to the costs for drugs and blood products. We concluded that the predicting of severity could be facilitating the decision for prompt treatment including dialysis, decreases the risk for unfavorable outcome and could be decreasing the hospital costs.},
 year = {2017}
}

Copy | Download

TY  - JOUR
T1  - Cost Effectiveness of Predicting Severity in Leptospirosis
AU  - Galya Ivanova Gancheva
Y1  - 2017/01/13
PY  - 2017
N1  - https://doi.org/10.11648/j.hep.20160101.14
DO  - 10.11648/j.hep.20160101.14
T2  - International Journal of Health Economics and Policy
JF  - International Journal of Health Economics and Policy
JO  - International Journal of Health Economics and Policy
SP  - 20
EP  - 25
PB  - Science Publishing Group
SN  - 2578-9309
UR  - https://doi.org/10.11648/j.hep.20160101.14
AB  - The prognosis of leptospirosis depends of severity, early diagnosis and prompt intensive treatment. Only few studies estimate the costs in outbreak of leptospirosis. We aimed to assess the cost effectiveness of predicting severity in leptospirosis by retrospective cohort study of 100 consecutive hospitalized patients with leptospirosis (1976-2015). The prices of service, investigations, drugs and no-medical costs were obtained from valid prices-table of the hospital. Total hospital costs per capita for mild, moderate and severe case were 1184 BGL (Bulgarian Lev=0.5 €), 2111 BGL and 8044 BGL, respectively (ratio 1 to 1.78 to 6.79). The costs for dialysis of severe cases were equal to the costs for drugs and blood products. We concluded that the predicting of severity could be facilitating the decision for prompt treatment including dialysis, decreases the risk for unfavorable outcome and could be decreasing the hospital costs.
VL  - 1
IS  - 1
ER  -

Copy | Download